SCHEMBL29494528

SCHEMBL29494528

Cc1ccc(NC(=O)[C@@H](N)CN)cc1C(=O)NCc1cccc2ncccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BLK P51451 2/20 0.47
▸ KCNB1 Q14721 6/20 0.46
▸ KCNH2 Q12809 3/20 0.46
▸ NSD2 O96028 1/20 0.43
▸ ADORA2A P29274 1/20 0.43
▸ ADORA1 P30542 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ ACLY P53396 1/20 0.41
▸ DGAT2 Q96PD7 1/20 0.41
▸ KCNA5 P22460 2/20 0.40
▸ BCHE P06276 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ F10 P00742 1/20 0.39
▸ CYP2C9 P11712 1/20 0.38
▸ BTK Q06187 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29494461 0.87 BLK (0.50) BLKKCNB1KCNH2NSD2ADORA2A
SCHEMBL29494507 0.86 BLK (0.52) BLKKCNB1KCNH2NSD2ADORA2A
SCHEMBL29494537 0.85 CLK1 (0.52) BLKKCNB1KCNH2NSD2ADORA2A
SCHEMBL29494565 0.79 KCNB1 (0.46) KCNB1KCNH2SMN1; SMN2KCNA5BCHE
SCHEMBL29494485 0.77 KCNH2 (0.45) KCNB1KCNH2ADORA2AADORA1SMN1; SMN2
SCHEMBL29494549 0.76 KLKB1 (0.49) KCNB1KCNH2LMNAMAPTHPGD
SCHEMBL29494545 0.74 BLK (0.43) BLK
SCHEMBL29494232 0.74 HSD17B10 (0.58) ALDH1A1MAPTHPGDMEN1KMT2A
SCHEMBL29494470 0.72 METTL3 (0.43) KCNB1KCNH2SMN1; SMN2KCNA5BCHE
SCHEMBL29494285 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022070048-A1 NOVEL AMIDE DERIVATIVES CADILA HEALTHCARE LIMITED (IN) 2022-04-07 — — WO disclosed
Send feedback